BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,400 | -36.7% | 25,000 | +66.7% | 0.00% | – |
Q2 2023 | $2,211 | +55.2% | 15,000 | 0.0% | 0.00% | – |
Q1 2023 | $1,425 | -4.9% | 15,000 | 0.0% | 0.00% | – |
Q4 2022 | $1,499 | +49.9% | 15,000 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $1,000 | -50.0% | 15,000 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $2,000 | – | 15,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atalaya Capital Management LP | 125,000 | $7,500 | 0.01% |
Q Global Advisors, LLC | 195,489 | $11 | 0.01% |
MMCAP International Inc. SPC | 325,000 | $18,200 | 0.01% |
PERISCOPE CAPITAL INC. | 867,072 | $48,556 | 0.01% |
MARSHALL WACE, LLP | 78,611 | $2,543,066 | 0.01% |
HGC Investment Management Inc. | 200,000 | $11,200 | 0.00% |
Spartan Fund Management Inc. | 75,000 | $4,200 | 0.00% |
EHP Funds Inc. | 125,186 | $7,010 | 0.00% |
COWEN AND COMPANY, LLC | 522,096 | $29,237 | 0.00% |
Radcliffe Capital Management, L.P. | 200,049 | $13,943 | 0.00% |